INTRODUCTION
Chemotherapy is one method of cancer treatment that works by inhibiting the growth of cancer cells or killing them. It is known that chemotherapy has many adverse side effects, such as hair loss, diarrhea, dry mouth, nausea, vomiting, and fatigue [1] . Therefore, it is important to evolve newer, more effective and more selective anticancer agents [2, 3] . In the present study, thiourea derivatives were developed as potential anticancer agents by modifying the structure of N-allylthiourea (ATU) [3] [4] [5] [6] [7] [8] . The choice of N-allylthiourea was due to its thiol group, a pharmacophore which is responsible for its biological activity. In addition, N-allylthiourea possesses a primary amine group (-NH 2 ). These groups allow for possible modifications that may lead to the development of ATU as an anticancer agent.
The chemical modification of the structure of Nallylthiourea was effected by reacting it with derivatives of benzoyl chlorides, resulting in generation of N-benzoyl-3-allylthiourea (A -D, Figure 1 ) using the Schotten-Baumann reaction [7] . In the first step, the amine group of Nallylthiourea reacted with the C-carbonyl of benzoyl chloride forming an amide, with the release of a proton and a chloride ion. The addition of the weak base, triethylamine (TEA) was necessary to neutralize the acidic proton formed, otherwise, the reaction would not have proceeded. Moreover, the addition of TEA blocked the protonation of the amine, a reaction which would have made it impossible for the base to react as a nucleophile [7] . Molecular modeling is usually conducted to examine the affinity of a ligand to its docking site through evaluation of the energy of drug-receptor binding. It has been shown that the evaluation of the interaction between a molecule and its docking protein involved in signal transduction may aid in identifying potential biological activity, as well as possible mechanisms of action [8, 10, 11] . Studies indicate that the 1M17, 1XKK, and 3POZ receptors are used as models of the epidermal growth factor receptor, EGFR [1, 12] . The standard ligands for these receptors are erlotinib, lapatinib, and TAK-285, respectively (TAK-285 is a selective EGFR inhibitor) [12] . In addition, these receptors resemble thiourea derivatives (EGFR/HER-2 inhibitors) which act by inhibiting the tyrosine kinase receptor (RTKs) in the intracellular region [13] [14] [15] . As inhibitors of EGFR, thiourea derivatives exhibit antiproliferation activities against tumor cells, including human breast cancer cells [3, 4, 14] .
One important parameter in molecular docking is the Rerank Score (RS). It is the energy of the ligand-receptor interaction, and a measure of bond energy between ligand and receptor [7, 8, 10] . The smaller the RS value, the more stable the bond between ligand and receptor. Therefore, a strong interaction implies a high biological activity [8] .
In the present study, the cytotoxicities of Nallylthiourea and its derivatives against MCF-7 breast cancer cell line were investigated using MTT assay [6, 16, 18] .
EXPERIMENTAL

Chemicals and reagents
N-Allylthiourea was purchased from Merck; 3, 4-dichlorobenzoyl chloride; 2, 4-dichlorobenzoyl chloride; 4-fluorobenzoyl chloride, and 4-methylbenzoyl chloride were products of SigmaAldrich. The reactions were monitored by Thin Layer Chromatography (TLC) carried out on silica gel 60 F 254 plates (Merck). Spot detection was performed at UV 254 nm [19] . Purification of the products was carried out by recrystallization [7, 19] .
Infrared spectra were measured using a PerkinElmer Spectrum One spectrophotometer and major absorptions were listed in cm- 
Cell culture
MCF-7 cell lines were obtained from the Laboratory of Gene Regulation at Graduate School of Biological Sciences, Nara Institute of Science and Technology (NAIST), Japan. The cells were grown on high-glucose Dulbecco's modified Eagle's medium (DMEM; Nacalai Tesque, Japan) containing 10 % fetal bovine serum (FBS) (Sigma, USA) and 1 % penicillinstreptomycin (Sigma, USA). The cells were harvested from culture dish using Trypsin-EDTA 0.25 % (Sigma, USA). The MTT reagent (5 mg/ml) was prepared by dissolving MTT (Nacalai, Japan) in phosphate-buffered saline (PBS).
Docking
Receptor and ligand were downloaded from Protein Data Bank. The ligand-receptor complexes were measured in the cavity. The 3-D structures of derivatives of N-allylthiourea were replaced to the fixed cavity. The ligands were docked towards the 1M17, 1XKK, and 3POZ receptors [12] . In the next step, Docking Score, Rerank Score, RMSD value, and the state of the environment of each compound derivative, such as hydrogen bonds, hydrophobic interactions, and electronic bonds, were determined [11, 16, 20] .
Synthesis of N-allylthiourea derivatives
N-Allylthiourea (0.025 moles) was dissolved in 20 mL of tetrahydrofuran. Benzoyl chloride derivatives (1 eq) and triethylamine (7 mL) were slowly added to the solution, stirred for 30 min at room temperature, and refluxed for 3 -4 h. Thereafter, the mixture was evaporated and washed with saturated aqueous sodium bicarbonate solution. The crude product was purified using column chromatography, with hexane: acetone (3:2); chloroform: hexane (5:2) and chloroform: hexane: ethyl acetate (1:6:2) as mobile phases at the indicated volume ratios. Recrystallization was done using ethanol: water at a volume ratio of 1:1 [7] .
EVALUATION OF CYTOTOXICITY
The cytotoxic effects of the derivatives against MCF-7 cells were evaluated using MTT assay. The cells were seeded into 96-well plates at a density of 8 x 10 3 cells/well and incubated at 37 °C for 24 h in an atmosphere containing 5 % CO 2 . The synthesized compounds were applied to the wells separately at different concentrations. After a 24-h incubation, MTT (5 mg/mL in PBS) was added to each well, and incubation was continued for 4 h at 37 o C to allow for formation of formazan crystals. Then, the reaction in each well was stopped by addition of the stopper reagent, a solution of 10 % sodium dodecylsulphate (SDS, Merck) in 0.01 N HCl (Merck), which also served to solubilize the formazan crystals. The plates were kept overnight in the dark at room temperature, after whuch the absorbance of the formazan solution in each well was read at 570 nm in an ELISA plate reader [2, 17, 18] .
RESULTS
Derivatives synthesized from N-allylthiourea
The desired derivatives were synthesized through nucleophilic substitution of Nallylthiourea with benzoyl chloride derivatives i.e. The interaction between the synthesized compounds (ligands) and amino acid residues are shown in Table1 and illustrated in 2D in Figure 2 .
The docking scores with respect to interaction with epidermal growth factor receptors were obtained using the Molegro Virtual Docker as shown in Table 2 .
Cytotoxicity of compounds A -D
The cytotoxic activities of the four derivatives were assessed using MTT assay, and the results are shown in Table 2 . The viabilities of the cells obtained from the measurement of the absorbance of formazan formed after treatment with MTT reagent, and representative morphologies of MCF-7 cell line after treatment are shown in Figure 3 .
DISCUSSION
In drug development and discovery, it is important to ensure that the drug-like physicochemical properties are maintained as described by Lipinsky's rule [9] . Most orallyadministered drugs are relatively small and moderately lipophilic molecules. Met793, Thr854
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Chemdraw
® is a helpful tool for predicting the lipophilicity of organic compounds [8] . The log P values of N-benzoyl-3-allylthiourea, N-allylthiourea and hydroxyurea are 2.0450, 0.0799, and -1.8000, respectively [7] . The higher the log P value, the more lipophilic the compound. Based on this parameter, the derivatives of Nallylthiourea are more lipophilic than Nallylthiourea and hydroxyurea. Thus, theoretically, the derivatives of N-allylthiourea can penetrate the cell membrane more easily, and so possess higher biological activities than the parent compound. The infrared spectra of the synthesized compounds A-D showed peaks above 1663 -1684 cm Based on in silico studies on the interactions between the ligands and EGF receptor, compound A interacted with amino acid residues such as Met769, Met793, and Thr854 through steric bonds and H-bonds. The interactions of other compounds (B, C and D) followed a similar pattern. The synthesized compounds exhibited the same ATP binding site for the H-bond binding of the amino acid residues Met793 and Met769 to the EGFR. However, N-allylthiourea and hydroxyurea bound amino acid residues only through steric bonds: H-bonds were not involved.
The presence of the lipophilic benzoyl group in N-benzoyl-3-allylthiourea resulted in enhanced biological activity due to stabilization of the ligand-receptor bond. This is consistent with the Rerank Score values of the N-allylthiourea derivatives (compounds A -D) which were lower than those of N-allylthiourea (lead compound) and hydroxyurea (clinically-used anticancer drog). The addition of substituents with certain lipophilic, electronic and steric properties improves the stability of ligand-receptor bonds.
The variation of substituents on N-benzoyl-3-allylthiourea caused differences in the number of interaction with amino acids. However, it did not bring about significant differences in Rerank Score values. From the results of in silico studies, some derivatives of N-allylthiourea were predicted to have greater anticancer activities than hydroxyurea. The results of in vitro cytotoxicity performed on MCF-7 cell lines using the MTT method revealed that the IC 50 of compounds A -D (0.21 -0.38 mM) were less than that of N-allylthiourea (IC 50 = 5.22 mM). These results indicate that the four derivatives of N-allylthiourea were more cytotoxic than the lead compound, N-allylthiourea. In addition, cytotoxicity studies revealed that all derivatives of N-allylthiourea were more cytotoxic against MCF-7 cell lines when compared to the commercial anticancer drug, hydroxyurea (IC 50 = 2.79 mM).
CONCLUSION
Molecular docking data have predicted that Nallylthiourea derivatives are epidermal growth factor receptor inhibitors. This is supported by results from cytotoxicity studies using MCF-7 cancer cell lines. Therefore, N-allylthiourea derivatives possess potential anticancer properties that can be harnessed for the development of new anticancer drugs. 
DECLARATIONS
